Results 81 to 90 of about 13,250 (212)

Acute Effects of Albuterol on Ventilatory Capacity in Children with Asthma

open access: yesPediatric Reports
Background: Children with asthma may have a reduced ventilatory capacity, which could lead to symptoms and early termination of a cardiopulmonary exercise test (CPET).
Michael W. H. Wong   +2 more
doaj   +1 more source

Albuterol as an adjunctive treatment to enzyme replacement therapy in infantile-onset Pompe disease

open access: yesMolecular Genetics and Metabolism Reports, 2017
Background: Early initiation of enzyme replacement therapy (ERT) with recombinant human acid alpha-glucosidase is an effective treatment for patients with infantile-onset Pompe disease (IOPD) but cannot prevent a slow progression of myopathy.
Yin-Hsiu Chien   +7 more
doaj   +1 more source

Effects of flow rate on transnasal pulmonary aerosol delivery of bronchodilators via high-flow nasal cannula for patients with COPD and asthma: protocol for a randomised controlled trial

open access: yesBMJ Open, 2019
IntroductionBoth in vitro and in vivo radiolabelled studies on nebulisation via high-flow nasal cannula showed that inhaled dose decreases as the administered gas flow increases. In our previous in vitro study, we investigated the effects of the ratio of
Jian Luo   +3 more
doaj   +1 more source

Inhibition of cholinesterases by albuterol carbamate [PDF]

open access: yes, 2019
OdreĎene su konstante brzine inhibicije dviju butirilkolinesteraza (BChE; EC 3.1.1.8) i dviju acetilkolinesteraza (AChE; EC 3.1.1.7) s racemičnim, (R)- i (S)- N,N-dimetilkarbamatom albuterola (4-(2-(tert-butilamino)-1-hidroksietil)-2-(hidroksimetil ...
Kerep, Robert
core  

Effects of albuterol isomers on the contraction and Ca2+ signaling of small airways in mouse lung slices

open access: yes, 2009
The beta(2)-adrenergic agonist, albuterol, is used as a bronchodilator by patients with asthma and consists of a racemic mixture of (R)- and (S)-albuterol. However, the action of the individual enantiomers is poorly understood.
Delmotte, Philippe   +1 more
core   +1 more source

Inadvertent Intoxication with Salbutamol, Treated with Hemodialysis: A Case Report and Brief Review of the Literature

open access: yesCase Reports in Nephrology and Dialysis
Introduction: Salbutamol is a moderately selective beta-2-adrenergic agonist. Various side effects can occur because of beta-1 and beta-2 receptor activation. Due to the large volume of distribution, it is not considered dialyzable.
Neva Bezeljak   +3 more
doaj   +1 more source

Comparison of two continuous nebulized albuterol doses in critically ill children with status asthmaticus

open access: yes, 2019
Objectives: Continuous nebulized albuterol is frequently used to treat children with status asthmaticus in the pediatric intensive care unit (PICU) but can have cardiovascular side effects. Limited data exist comparing different dosages.
Ada T. Lin (6830912)   +2 more
core   +1 more source

Historical cohort study examining comparative effectiveness of albuterol inhalers with and without integrated dose counter for patients with asthma or chronic obstructive pulmonary disease

open access: yesJournal of Asthma and Allergy, 2016
David B Price,1,2 Anna Rigazio,2 Mary Buatti Small,3 Thomas J Ferro,3 1Academic Primary Care, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK; 2Research in Real-Life Ltd, Cambridge, UK; 3Teva Pharmaceuticals, Frazer, PA, USA ...
Price DB   +3 more
doaj  

Safety, Efficacy, and Feasibility of Nebulized Long-Acting Bronchodilators vs Short-Acting Bronchodilators in Hospitalized Patients With Acute Exacerbations of COPD

open access: yesCHEST Pulmonary
Background: Long-acting bronchodilators are preferred over short-acting bronchodilators in patients with stable COPD, but prospective studies are needed to determine the safety and efficacy of nebulized long-acting bronchodilators in hospitalized ...
Rajiv Dhand, MD   +15 more
doaj   +1 more source

Assessment of Airway Bronchodilation by Spirometry Compared to Airway Obstruction in Young Children with Asthma

open access: yesCanadian Respiratory Journal, 2016
A reversibility test by an increase of greater than 12% in FEV1 can support a diagnosis of asthma and alter a patient’s treatment plan but may not be applicable to the young ages.
Daphna Vilozni   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy